Patient safety
Our stance on safety and transparency
We are deeply concerned about the widespread misinformation surrounding peptides and weight-loss medications. Here is exactly where we stand — and why it matters for your health.
We are deeply concerned about the widespread misinformation surrounding peptides and weight-loss medications labeled "Research Use Only" or "Not for Human Consumption."
These products are not approved by the FDA for human use. When they are marketed for weight loss, recovery, or anti-aging while carrying that label, they operate in a legal and safety gray area. There is no guarantee of purity, sterility, correct dosing, or quality control. Contamination, mislabeling, and serious health risks have been documented in this market. The FDA has issued multiple warning letters to companies selling these products for human use despite the disclaimers.
We do not source or recommend research-only products sold for human use. We do not source or recommend research-only products sold for human use. At Dominia, every treatment begins with a proper medical evaluation by licensed providers. We work exclusively with regulated compounding pharmacies that operate under strict standards. Transparency, safety, and clinical accountability are non-negotiable.
What this means in practice
Licensed providers only
Every patient at Dominia Health is evaluated by a licensed nurse practitioner or physician before any treatment is prescribed. We do not dispense medications without a proper clinical assessment.
Regulated compounding pharmacies
We work with a licensed 503A/503B compounding pharmacy.
No "research use only" products
We do not source, recommend, or prescribe products labeled "Research Use Only" or "Not for Human Consumption" for patient use — regardless of how they are marketed elsewhere.
Transparent clinical standards
We share the evidence base — including its limitations — for every treatment we offer. If high-quality data is limited, we say so. Patients deserve honest information to make informed decisions.
Why this matters
The market for compounded peptides and GLP-1 medications has grown rapidly, and with it the number of products sold online with minimal oversight. The FDA has documented adverse events — including hospitalizations — linked to compounded semaglutide and other peptides sourced outside regulated pharmacy channels.
"Research Use Only" labels are not a legal loophole that makes a product safe for human use. They are a signal that the product has not been evaluated for safety, efficacy, or quality in humans. Purchasing and using these products carries real risk, and the burden of that risk falls entirely on the patient.
We built Dominia Health because we believe women deserve access to evidence-informed care delivered by providers who are accountable — not anonymous storefronts with no clinical oversight.
Ready to get started the right way?
Every Dominia Health consultation begins with a thorough medical evaluation by a licensed provider. No shortcuts. No gray-area products.